Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,941 | 9,266 | 17,378 | -12,151 | -72,184 |
| Depreciation Amortization | 89 | 45 | 4 | -22 | -603 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,254 |
| Accounts payable and accrued liabilities | -1,321 | -1,615 | 822 | 686 | 517 |
| Other Working Capital | -45,556 | -43,713 | -39,857 | 773 | 3,435 |
| Other Operating Activity | 11,026 | 9,355 | 4,862 | 1,512 | 27,656 |
| Operating Cash Flow | $-33,822 | $-26,663 | $-16,791 | $-9,202 | $-43,432 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 24,528 | 24,528 | 21,528 | 17,028 | 14,085 |
| Investing Cash Flow | $24,528 | $24,528 | $21,528 | $17,028 | $14,085 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,694 | 13,694 | 6,322 | 798 | 525 |
| Other Financing Activity | -456 | -456 | -220 | 0 | 0 |
| Financing Cash Flow | $13,238 | $13,238 | $6,103 | $798 | $525 |
| Beginning Cash Position | 21,513 | 21,513 | 21,513 | 21,513 | 50,335 |
| End Cash Position | 25,457 | 32,616 | 32,352 | 30,136 | 21,513 |
| Net Cash Flow | $3,944 | $11,103 | $10,840 | $8,624 | $-28,822 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,822 | -26,663 | -16,791 | -9,202 | -43,432 |
| Free Cash Flow | -33,822 | -26,663 | -16,791 | -9,202 | -43,432 |